跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-PREGABALIN pregabalin 300 mg capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
APO-PREGABALIN pregabalin 300 mg capsule blister
Approved
STANDARD
APO-PREGABALIN pregabalin 300 mg capsule blister
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ac2f007b394d5df0
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
ac2f007b394d5df0
Product Name
APO-PREGABALIN pregabalin 300 mg capsule blister
Artg Id
308086
Artg Name
APO-PREGABALIN pregabalin 300 mg capsule blister
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2019-07-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8645379a85e330eb6a7404c2bcec59f1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/16000cbf97806ca2b4efdf85bb9186ad.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ac2f007b394d5df0
Type
Standard
Back to TGA Approvals